1 April, 2011
Download Brochure
Email Updates
Testimonials

The 10th Annual European Pharmaceutical Supply Chain Conference

Welcome to LogiPharma 2010

LogiPharma took place in Geneva on the 27th- 29th April 2010. Attracting over 300 pharma supply chain professionals for 3 days of networking, learning and benchmarking with their peers.

Developed in partnership with a specially appointed advisory board which included Pifzer and Merck & Co, this year’s meeting mirrored and addressed the key business challenges that are facing the industry.

If you weren’t able to attend the event contact us for details on purchasing the conference proceedings for £299 + VAT

LogiPharma 2010

Key topics covered in 2010

Some of the key topics covered at LogiPharma 2010 included:

  • Improving supply chain agility to reduce response time
  • Improving supply chain security and visibility to minimize risk of counterfeits
  • Forecasting and demand planning in a volatile environment by working closely with sales and marketing
  • Integrating supply chains to align the organization with a changing product portfolio
  • Utilizing cost-effective outsourcing to reduce liability and improve supply chain flexibility
  • Cutting waste using lean tools
  • Improving customer service along the supply chain while reducing working capital
  • Adopting Best Practices From The FMCG Industry To Optimize Inventories And Improve Profitability
  • Identifying When Direct Distribution Models Are Appropriate To Minimize Risk

New!

Speaker Highlights in 2010

WBR would like to thank all of the speakers who contributed to LogiPharma 2010. Some of the highlights from the event include:

  • Philippe Francois, Vice President Supply Chain EMEA, Baxter (NEW)
  • Christian Riediger, PS PH Supply Chain Management, Supply Strategy & Optimization, Bayer Schering Pharma AG (NEW)
  • Inal Kose, Pharm, FDF Warehouse Specialist, Responsible Manager, Sandoz Turkey(NEW)
  • Christoph Feldmann, Director Logistics Strategy & Business Solutions Europe/AFME, Pfizer (Largest Pharma)
  • Hillel West, Executive Director, Supply Chain Strategy, Teva (Largest Generic Manufacturer)
  • Birk Vanderweeen, Head, Distribution, EMEA, AstraZeneca (NEW)
  • Christele Hadjadj, Director, Supply Chain, Bristol Myers Squibb (NEW)
  • Jean-Marc Bobée, Director, Anti-Counterfeiting Strategy, Industrial Affairs, Sanofi Aventis
  • Daniel Graf, Global Head of Supply Chain, Solvay
  • Oliver Glemser, Global Supply Chain Director, Ferring International Center (NEW)
  • Dirk Broeckx, Secretary General, Belgian Pharmacists Association
Theme1 Master Page PageName:twocolumnpage.aspx